Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method
Recruiting
Observational Study
Neuroblastoma
Ewing Sarcoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 2 – 45
- Sex
- Any
- Study type
- Observational
- Participants needed
- 89 (estimated)
- Sponsor
- University Hospital, Clermont-Ferrand · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In prepubertal patients, cryopreservation of ovarian or testicular tissue is currently the only available method for fertility preservation prior to gonadotoxic cancer treatments. However, this approach carries the risk of reintroducing malignant cells upon autotransplantation, particularly in cases of metastatic cancers such as neuroblastoma and Ewing sarcoma. Therefore, it is crucial to employ h…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women of any age diagnosed with a benign cyst requiring laparoscopy may be included.
* Men of any age diagnosed with a non-obstructive azoospermia may be included.
* Prepubertal girls and boys diagnosed with neuroblastoma or Ewing sarcoma during infancy may be included.
* Capa…
Contacts